Results 291 to 298 of about 46,900 (298)

Dipeptidyl peptidase IV (DPP IV) inhibitors: a newly emerging drug class for the treatment of type 2 diabetes

Diabetes and Vascular Disease Research, 2006
Brian D Green, Peter R Flatt, Clifford J Bailey   +2 more
exaly  

Isolation and characterization of peptides with dipeptidyl peptidase IV (DPPIV) inhibitory activity from natto using DPPIV from Aspergillus oryzae

Food Chemistry, 2018
Hiroshi Tachi
exaly  

Cardiovascular Effects of Dipeptidyl Peptidase-4 Inhibitors: From Risk Factors to Clinical Outcomes

Postgraduate Medicine, 2013
André J Scheen
exaly  

Dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes: comparison, efficacy and safety

Expert Opinion on Pharmacotherapy, 2013
Carolyn F Deacon, Jens J Holst
exaly  

Alogliptin, a Dipeptidyl Peptidase‐4 Inhibitor, Alleviates Atrial Remodeling and Improves Mitochondrial Function and Biogenesis in Diabetic Rabbits

Journal of the American Heart Association, 2017
Yungang Zhao, Ning Jiang, Jiuchun Qiu
exaly  

Dipeptidyl peptidase-4 (DPP-4) inhibitors

British Journal of Cardiology, 2017
openaire   +1 more source

Synthesis of a Dipeptidyl Peptidase 4 Inhibitor

Synfacts, 2009
openaire   +1 more source

Synthesis of a Dipeptidyl Peptidase-4 Inhibitor

Synfacts, 2019
openaire   +1 more source